Gilder Gagnon Howe & CO LLC Repare Therapeutics Inc. Transaction History

Gilder Gagnon Howe & CO LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$11.38 - $21.88 $193 - $371	-17 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$19.66 - $28.11 $63,187 - $90,345	-3,214 Reduced 99.47%	17 $0
Q3 2021 Nov 15, 2021	SELL	$25.71 - $35.24 $51 - $70	-2 Reduced 0.06%	3,231 $85,000
Q1 2021 May 17, 2021	SELL	$25.89 - $44.46 $77 - $133	-3 Reduced 0.09%	3,233 $99,000
Q4 2020 Feb 16, 2021	SELL	$23.42 - $39.5 $70 - $118	-3 Reduced 0.09%	3,236 $111,000
Q3 2020 Nov 16, 2020	SELL	$21.55 - $33.92 $10,171 - $16,010	-472 Reduced 12.72%	3,239 $100,000
Q2 2020 Aug 14, 2020	BUY	$30.8 - $32.99 $114,298 - $122,425	3,711 New	3,711 $115,000

35.4M

50K

300

Ticker RPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,937,800
Market Cap $119M
Description
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.